AEON Biopharma Appoints Industry Veteran Rob Bancroft as Chief Executive Officer [Yahoo! Finance]
Smith & Nephew SNATS, Inc. (SNN)
Last smith & nephew snats, inc. earnings: 8/1 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
smithoptics.com
Company Research
Source: Yahoo! Finance
IRVINE, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the treatment of multiple therapeutic indications, announced today the appointment of Rob Bancroft as President and Chief Executive Officer, effective April 29, 2025. Mr. Bancroft will also join AEON's Board of Directors. “We are excited to welcome Rob as the new President and Chief Executive Officer of AEON. He is an exceptional leader who brings a wealth of experience in the therapeutic toxin industry, and a strong track record of building value through the execution of well-defined strategies,” commented Mr. Jost Fischer, Chairman of the AEON Board and Interim President and Chief Executive Officer. “Rob is uniquely positioned to hit the ground running and lead the rest of the AEON team as we continue to advance our ABP-450 program along the planned 351(k) biosimilar regulator
Show less
Read more
Impact Snapshot
Event Time:
SNN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNN alerts
High impacting Smith & Nephew SNATS, Inc. news events
Weekly update
A roundup of the hottest topics
SNN
News
- Smith & Nephew at Risk for Guidance Cuts in 2026, RBC Says [Yahoo! Finance]Yahoo! Finance
- Smith & Nephew SNATS (NYSE:SNN) was downgraded by analysts at Royal Bank Of Canada from an "outperform" rating to a "sector perform" rating.MarketBeat
- Smith & Nephew SNATS (NYSE:SNN) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=SNN&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street ZMarketBeat
- Smith & Nephew plc (SNN) Analyst/Investor Day Transcript [Seeking Alpha]Seeking Alpha
- Smith & Nephew plc (LON:SN.) is favoured by institutional owners who hold 88% of the company [Yahoo! Finance]Yahoo! Finance
SNN
Sec Filings
- 12/8/25 - Form 6-K
- 12/1/25 - Form 6-K
- 11/19/25 - Form 6-K
- SNN's page on the SEC website